<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Surgical treatment of erectile dysfunction
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Surgical treatment of erectile dysfunction
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Surgical treatment of erectile dysfunction
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen Lazarou, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jerome P Richie, MD, FACS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 14, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Erectile dysfunction (ED) affects approximately 50 million American men each year. The introduction of oral phosphodiesterase inhibitors revolutionized the care of these patients, but surgery still has a clear role when these inhibitors and other approaches fail or are contraindicated.
        </p>
        <p>
         The surgical management of erectile dysfunction, including implantation of penile prostheses and penile vascular (arterial and venous) reconstruction, is reviewed here. The correction of curvature abnormalities (ie, Peyronie's disease) and other aspects of erectile dysfunction are discussed elsewhere.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6840.html" rel="external">
          "Epidemiology and etiologies of male sexual dysfunction"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7468.html" rel="external">
          "Evaluation of male sexual dysfunction"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7469.html" rel="external">
          "Treatment of male sexual dysfunction"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8096.html" rel="external">
          "Surgical management of Peyronie's disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical management of erectile dysfunction (ED) should be reserved for men who cannot use, or who have not responded to, first- and second-line therapies. (See
         <a class="medical medical_review" href="/z/d/html/7469.html" rel="external">
          "Treatment of male sexual dysfunction", section on 'General principles'
         </a>
         .)
        </p>
        <p>
         Patients with curvature abnormalities (ie, Peyronie's disease) with ED or significant risk factors for future ED are candidates for the placement of a penile prosthesis at the time of their reconstructive surgery. (See
         <a class="medical medical_review" href="/z/d/html/8096.html" rel="external">
          "Surgical management of Peyronie's disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Contraindications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Implantation of a penile prosthesis is contraindicated in the presence of infection (eg, systemic, pulmonary, urinary tract, cutaneous). The penis and scrotum must be free of any dermatitis, wounds, or other cutaneous lesions.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          PREOPERATIVE PREPARATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         A thorough review of the patient's medical and surgical history, and a physical examination including a complete urologic examination, should be performed. History and physical examination are directed at evaluating the efficacy of previous nonsurgical treatments, identifying medical risk factors or other conditions (eg, infection) that may contraindicate the procedure, and confirming the presence and nature of erectile dysfunction.
        </p>
        <p>
         The patient's manual dexterity must be considered when choosing the type of penile implant. If the patient cannot operate his device, he must have a willing and able partner who can assist him. Semirigid devices generally require less manual dexterity to operate. (See
         <a class="local">
          'Choice of implant'
         </a>
         below.)
        </p>
        <p>
         The author performs a penile duplex ultrasound study following intracorporeal injection of a vasodilating agent to assess tumescence and vascular flow prior to placement of a penile prosthesis. This study assesses the tumescence, length, and girth of the penis, which help guide the choice of implant. The presence of vascular insufficiency and penile curvature can also be determined.
        </p>
        <p>
         For men who are potential candidates for penile revascularization, a preoperative pelvic and penile arteriogram is necessary to determine the location and severity of vascular obstruction. (See
         <a class="medical medical_review" href="/z/d/html/7468.html" rel="external">
          "Evaluation of male sexual dysfunction", section on 'Evaluation for cardiovascular disease'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Medical risk evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most men with erectile dysfunction not due to sequelae of trauma will have been screened for cardiovascular disease, such as hyperlipidemia, hypertension, and diabetes, prior to institution of medical therapy. Repeat evaluation may be needed prior to surgery since erectile dysfunction is often a marker of cardiovascular disease [
         <a href="#rid1">
          1-4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7468.html" rel="external">
          "Evaluation of male sexual dysfunction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">
          "Evaluation of cardiac risk prior to noncardiac surgery"
         </a>
         .)
        </p>
        <p>
         Men with significant cardiovascular disease are not good candidates for penile revascularization; however, if their cardiac risk is not high, they may be a candidate for a penile implant. (See
         <a class="local">
          'Penile prostheses'
         </a>
         below and
         <a class="local">
          'Penile revascularization'
         </a>
         below.)
        </p>
        <p>
         Diabetes mellitus is associated with a higher risk of perioperative infection. While improving control of diabetes mellitus before surgery has reduced the risk of infection for some surgeries, a consistent benefit for patients undergoing penile implants has not been found [
         <a href="#rid5">
          5-8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1753.html" rel="external">
          "Perioperative management of blood glucose in adults with diabetes mellitus"
         </a>
         .)
        </p>
        <p>
         Patients should avoid taking
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         and nonsteroidal anti-inflammatory medications for seven days prior to the procedure as these may increase the risk of postoperative bleeding. (See
         <a class="medical medical_review" href="/z/d/html/4814.html" rel="external">
          "Perioperative medication management", section on 'Medications affecting hemostasis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Antimicrobial prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic prophylaxis with activity against flora of the skin and genitourinary tract should be administered within one hour of incision [
         <a href="#rid9">
          9
         </a>
         ]. Appropriate choices are given in the table  (
         <a class="graphic graphic_table graphicRef129971" href="/z/d/graphic/129971.html" rel="external">
          table 1
         </a>
         ). While the American Urological Association guidelines suggest that prophylaxis should be discontinued within 24 hours of the procedure, these guidelines are not specific to the placement of prostheses [
         <a href="#rid9">
          9
         </a>
         ]. Some surgeons also administer an antifungal agent, such as amphotericin, preoperatively, as approximately 11 percent of cultures identified at time of penile explantation for infection identify
         <em>
          Candida albicans
         </em>
         [
         <a href="#rid10">
          10
         </a>
         ]. Oral antibiotics are administered for one week following placement of a penile implant. The author typically uses oral
         <a class="drug drug_general" data-topicid="8673" href="/z/d/drug information/8673.html" rel="external">
          amoxicillin
         </a>
         /clavulanate,
         <a class="drug drug_general" data-topicid="9231" href="/z/d/drug information/9231.html" rel="external">
          cephalexin
         </a>
         , or
         <a class="drug drug_general" data-topicid="9554" href="/z/d/drug information/9554.html" rel="external">
          levofloxacin
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults", section on 'Genitourinary surgery'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Patient counseling
         </span>
         <span class="headingEndMark">
          —
         </span>
         A thorough preoperative discussion is essential and should review preparation, complications, and outcomes of surgery.
        </p>
        <p>
         The patient considering prosthesis implantation should be informed of the potential complications, which include but are not limited to wound infection, urethral and bladder injury, penile shortening, impaired sensation, mechanical failure (ie, inflatable implants), or the potential need for reoperation due to implant erosion or infection. (See
         <a class="local">
          'Implant complications'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          ANATOMY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The penis is composed of three cylindrical masses (two corpora cavernosa, corpora spongiosum) bounded by fibrous tissue and covered with skin  (
         <a class="graphic graphic_figure graphicRef66964" href="/z/d/graphic/66964.html" rel="external">
          figure 1
         </a>
         ). The tunica surrounds the corpora cavernosa and is composed of collagen arranged in circular and longitudinal layers. The inner circumferential layer contains intracavernosal pillars that help tether the corporal bodies, limiting overexpansion. The outer longitudinal collagen fibers run from the glans penis to the proximal crura at the base of the penis.
        </p>
        <p>
         The main arterial vascular supply is derived from the internal pudendal artery, which is a branch of the internal iliac artery. The internal pudendal becomes the common penile artery, which branches into the dorsal, bulbourethral, and cavernous arteries. The cavernous or cavernosal artery supplies the helicine arterioles supplying the spongy trabecular tissues that store and trap blood during an erection.
        </p>
        <p>
         The cavernosal tissue is drained by venules that coalesce to form subtunical venules before exiting the tunica albuginea as emissary veins. The emissary veins run obliquely between the inner and outer layers of the tunica. These veins drain the corporal bodies; a septum between the corporal bodies allows vascular communication between them. The emissary veins unite, forming the circumflex, periurethral, and superficial dorsal veins.
        </p>
        <p>
         Erectile physiology is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6840.html" rel="external">
          "Epidemiology and etiologies of male sexual dysfunction", section on 'Erectile physiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          PENILE PROSTHESES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Penile prostheses have been used for the treatment of erectile dysfunction since the 1950s. The first implants consisted of rib cartilage, modeled after the os penis of some animals. Subcutaneous acrylic splints, polyethylene rods, and pure silicone implants were used in the past. A major advance in prosthetic surgery has been the placement of devices within the paired corpora cavernosa, providing improved cosmetic and functional results [
         <a href="#rid11">
          11-15
         </a>
         ].
        </p>
        <p>
         Early inflatable prosthetic models were plagued by mechanical dysfunction, aneurysm formation, and S-shaped deformities [
         <a href="#rid16">
          16
         </a>
         ]. Over time, inflatable devices have become more dependable, with high rates of patient satisfaction. Following the introduction of
         <a class="drug drug_general" data-topicid="9643" href="/z/d/drug information/9643.html" rel="external">
          sildenafil
         </a>
         in 1998, the use of penile prostheses dropped considerably. However, the subsequent development of tolerance to medical therapy led to a rebound in the number of implanted penile prostheses that exceeded pre-1998 levels [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Types
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two types of penile implants are commercially available, with inflatable prosthetics accounting for the majority of implants [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Semirigid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Semirigid rods have been available for several decades. They are easy to use but result in a permanent erection  (
         <a class="graphic graphic_picture graphicRef81251" href="/z/d/graphic/81251.html" rel="external">
          picture 1
         </a>
         ). Although semirigid devices continue to be used successfully, they make up fewer than 10 percent of all implanted penile prostheses [
         <a href="#rid19">
          19
         </a>
         ]. They are ideal for patients in whom the cosmetic advantages of the inflatable devices are not as important as the ease of use and reduced incidence of comparative mechanical failure.
        </p>
        <p>
         The mechanical reliability of malleable devices is excellent, and they are easy to implant via subcoronal, penoscrotal, or infrapubic incisions. Because they are malleable, the penis can be bent down close to the body to be less noticeable under clothing. Malleable prostheses bend with relative ease, but they may have some springback. This means that they have some "memory" as to their original shape and will return to some degree to their original straight position. The degree of springback determines the ease of concealment for the patient.
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Inflatable
         </span>
         <span class="headingEndMark">
          —
         </span>
         The inflatable prostheses are designed to approximate the rigidity and flaccidity of the normally functioning penis. These devices consist of two hollow cylinders placed within the corpora cavernosa, a
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         reservoir and pump  (
         <a class="graphic graphic_figure graphicRef54550" href="/z/d/graphic/54550.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid20">
          20
         </a>
         ]. Designs and materials for inflatable penile prostheses have continued to improve over time with high rates of patient satisfaction (&gt;90 percent) [
         <a href="#rid18">
          18,21-30
         </a>
         ].
        </p>
        <p>
         Inflatable prostheses are generally available in two- or three-piece designs [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Two-piece
         </strong>
         – Two-piece penile prostheses are comprised of intracavernosal cylinders attached to a small scrotal pump  (
         <a class="graphic graphic_picture graphicRef79647" href="/z/d/graphic/79647.html" rel="external">
          picture 2
         </a>
         ). Inflation of the device is achieved by squeezing the pump, which redistributes
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         from a reservoir in the rear of the cylinders to the front of the cylinders, creating rigidity in the outward aspect of the corpora cavernosa, thus creating an erection. Deflation is accomplished by bending the cylinders (and the penis), which activates a valve allowing fluid to return to the reservoir area. In the flaccid state, the two-piece prosthesis appears fuller than a multicomponent device, because less fluid is transferred to the smaller reservoir area.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The main advantage of the two-piece prosthesis is simplified operative placement because of the integrated reservoir (ie, no need to fill or connect). The two-piece implant is particularly useful when prior pelvic or inguinal surgery prevents the placement of a separate reservoir. Another approach coats the implant with a hydrophilic coating that reduces bacterial adherence and absorbs antibiotics when the implant is immersed in antibiotic-containing solution [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patient satisfaction has been shown to be as high as 96 percent and mechanical failure rates less than 5 percent over a five-year period [
         <a href="#rid14">
          14,21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Three-piece
         </strong>
         – The three-piece implant consists of penile cylinders, a scrotal pump, and a reservoir  (
         <a class="graphic graphic_picture graphicRef71063" href="/z/d/graphic/71063.html" rel="external">
          picture 3
         </a>
         ). Erection is achieved by repeatedly squeezing the pump; each compression transfers fluid from the reservoir to the intracorporeal cylinders until adequate rigidity is achieved  (
         <a class="graphic graphic_figure graphicRef54550" href="/z/d/graphic/54550.html" rel="external">
          figure 2
         </a>
         ). Pressing a valve mechanism in the scrotal pump causes fluid to flow from the cylinders back to the reservoir.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Variations
         </strong>
         – Special designs provide increased length in addition to width, and rear tip extenders can be added to the back of the cylinders to modify length further. Other designs are available to accommodate fibrotic corpora or the shortened penis. Some penile prostheses have smaller reservoirs and reservoirs that are more easily concealed submuscularly due its flattened shape; others have a lockout valve to prevent cylinder autoinflation (ie, fluid unintentionally transferred from reservoir to cylinders) [
         <a href="#rid24">
          24,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Autoinflation is typically due to compression on the reservoir (ie, abdominal straining) and causes partial unintended erections, which may be socially awkward. By preventing autoinflation, the lockout valve also permits the surgeon to place the reservoir in sites prone to the effects of increased abdominal pressure, such as an epigastric, subcutaneous, or subrectus location.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Antimicrobial-coated implants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic coatings provide an effective way to reduce the risk of perioperative infection and are available with some inflatable prostheses. InhibiZone is a US Food and Drug Administration (FDA)-approved surface treatment of
         <a class="drug drug_general" data-topicid="9864" href="/z/d/drug information/9864.html" rel="external">
          rifampin
         </a>
         and
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          minocycline
         </a>
         [
         <a href="#rid28">
          28,32
         </a>
         ]. Resist combines an antibiotic solution of
         <a class="drug drug_general" data-topicid="8489" href="/z/d/drug information/8489.html" rel="external">
          gentamicin
         </a>
         and
         <a class="drug drug_general" data-topicid="9052" href="/z/d/drug information/9052.html" rel="external">
          bacitracin
         </a>
         [
         <a href="#rid33">
          33
         </a>
         ]. These coatings are impregnated onto the external silicone surfaces of the implanted components. Another approach coats the implant with a hydrophilic coating that reduces bacterial adherence and absorbs antibiotics when the implant is immersed in antibiotic-containing solution [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Several retrospective studies have reported significant reductions in infection rates with antibiotic-treated implants compared with nontreated implants [
         <a href="#rid32">
          32,33,35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Choice of implant
         </span>
         <span class="headingEndMark">
          —
         </span>
         In most cases, the choice of prosthesis type is a personal one based upon the patient's preference and perception of function and cosmesis. As a general rule, most men prefer the more natural capabilities of inflatable prostheses.
        </p>
        <p>
         Other factors may be important in specialized populations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Older men, especially those with limited mental or manual dexterity, should be offered a semirigid or two-piece inflatable implant because manipulating the pump and deflation mechanisms of three-piece inflatable devices may be challenging.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with diminished sensation in the penis (ie, spinal cord injury) should be offered an inflatable device to decrease the potential for skin or urethral erosion due to prolonged excessive pressure on the rods [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         The placement of penile prostheses is usually performed as an outpatient procedure under general, spinal, or epidural anesthesia, but it can be also be performed with local anesthesia and monitored sedation [
         <a href="#rid38">
          38,39
         </a>
         ]. Following the procedure, the patient is instructed not to use the device for four to six weeks to ensure adequate healing.
        </p>
        <p>
         Placement of these devices can be performed through a penoscrotal, infrapubic, or subcoronal approach. The operative area is shaved immediately prior to surgery and the skin prepared. (See
         <a class="medical medical_review" href="/z/d/html/4044.html" rel="external">
          "Overview of control measures for prevention of surgical site infection in adults"
         </a>
         .)
        </p>
        <p>
         Corporotomies are made in the corpora cavernosa, which are then dilated and measured. The appropriate-sized device is chosen, both in terms of length and diameter. The pump is placed in the scrotum. If a three-piece device is chosen, the reservoir is typically placed preperitoneally behind the rectus muscle, either through the external inguinal ring or via a separate lower abdominal incision. Reservoirs can also be placed ectopically and above the transversalis fascia.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Considerations for Peyronie's disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Either a two- or three-piece prosthesis can be used in the management of Peyronie's disease. For men with significant plaques and curvature, a "modeling" procedure may be performed in which the tunical plaque is fractured over an inflated cylinder at the time of implantation. In this procedure, the penis is forcibly bent in a direction opposite the curvature [
         <a href="#rid40">
          40
         </a>
         ]. Bending pressure is maintained on the penis for 90 seconds. When successful, the modeling procedure results in splitting and rupturing of the fibrotic plaques.
        </p>
        <p>
         If the plaque is not able to be fractured, then a combination of plaque incision and grafting may be performed [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8096.html" rel="external">
          "Surgical management of Peyronie's disease", section on 'Grafting'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Implant complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most serious complication of penile prosthesis implantation is infection; however, mechanical failure can also occur, with surgical revision required in 5 to 15 percent of men over one to seven years [
         <a href="#rid19">
          19,21-23,41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Implant infection historically occurred in up to 3 percent of cases, but modern studies indicate closer to 1 percent; patients with diabetes, spinal cord injury, or previous implants may have higher infection rates [
         <a href="#rid5">
          5,6,42
         </a>
         ]. Infection usually occurs within three months of implantation [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         Most implant infections occur as a result of intraoperative contamination with normal skin flora such as
         <em>
          Staphylococcus epidermidis
         </em>
         ; these organisms have been isolated from 30 to 50 percent of infected prostheses [
         <a href="#rid5">
          5,44,45
         </a>
         ]. Aerobic gram-negative organisms, such as
         <em>
          Proteus
         </em>
         ,
         <em>
          Pseudomonas
         </em>
         ,
         <em>
          Escherichia coli
         </em>
         , and
         <em>
          Serratia
         </em>
         , also cause implant infections. Cases of infection due to
         <em>
          Candida albicans
         </em>
         , mycobacteria, and gonococci can occur [
         <a href="#rid43">
          43,46,47
         </a>
         ].
        </p>
        <p>
         The risk of implant infections can be reduced with meticulous attention to sterile technique and delay of implantation until after adequate treatment of any known infections [
         <a href="#rid48">
          48
         </a>
         ]. Antibiotic-coated prostheses may also be useful for prevention of infection. (See
         <a class="local">
          'Antimicrobial-coated implants'
         </a>
         above.)
        </p>
        <p>
         Clinical manifestations include penile pain, erythema, and induration over the prosthesis or device extrusion. Subclinical infections manifest most commonly with chronic penile pain [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
         Management of suspected infection usually requires surgical exploration. Early culture, debridement, and irrigation facilitate microbiological diagnosis and may reduce the likelihood that a biofilm will form on the implants [
         <a href="#rid50">
          50-52
         </a>
         ]. Material from the wound should be sent for gram stain and culture with sensitivity. If the wound gram stain is negative (ie, no organisms, no white cells), the site should be thoroughly irrigated, the prosthesis can be left in place, and the wound can be closed [
         <a href="#rid42">
          42,51
         </a>
         ]. The presence of frank purulence usually necessitates removal of the entire device and vigorous wound irrigation.
        </p>
        <p>
         Empiric therapy prior to the return of culture results should cover both gram-positive skin flora and aerobic enteric bacterial flora (eg,
         <em>
          E. coli
         </em>
         ,
         <em>
          Klebsiella
         </em>
         spp). Appropriate empiric regimens include
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 2
         </a>
         ) and either
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         (1 g IV daily) or
         <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">
          ciprofloxacin
         </a>
         (400 mg IV every 12 hours or 500 to 750 mg orally twice daily). Antibiotic selection should be tailored to culture and sensitivity results when available.
        </p>
        <p>
         The duration of therapy depends on individual circumstances:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For eradication of infection following implant removal, 7 to 14 days of therapy is usually effective. Reimplantation of a new prosthesis can be considered a minimum of three months after treatment is completed if there are no ongoing signs of infection [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For implant salvage, the duration of therapy depends upon the clinical response to therapy [
         <a href="#rid42">
          42
         </a>
         ]. Treatment with parenteral therapy is indicated until signs of infection have resolved, and many clinicians transition to oral antibiotics; the duration of oral treatment depends on the clinical scenario. In these cases, it is important to have a definitive microbiological diagnosis to guide decisions about route and duration of treatment.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          PENILE REVASCULARIZATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most commonly performed technique for penile revascularization involves anastomosis of the inferior epigastric artery to the dorsal penile artery (dorsal artery arterialization). The original technique, which is less often performed, uses the dorsal penile vein as the distal target (dorsal vein arterialization).
        </p>
        <p>
         Arterial revascularization relies on the inferior epigastric artery. A paramedian abdominal incision is made and the inferior epigastric vessels dissected from the lower surface of the rectus muscle. The inferior epigastric artery is then anastomosed to the deep penile artery (Hauri technique) [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         Penile dorsal artery arterialization requires microsurgical skill and is generally performed in specialized centers [
         <a href="#rid48">
          48,54-57
         </a>
         ]. An analysis of 25 trials identified risk factors associated with failure of penile revascularization, which include smoking, diabetes mellitus, hypertension, hyperlipidemia, history of radiation therapy, coronary artery disease, alcohol abuse, obesity, cavernosal fibrosis, and distal arterial disease [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         Postoperative complications may include penile edema, penile numbness, and penile shortening due to scar entrapment.
        </p>
        <p>
         Reasonable success rates for penile revascularization are achieved in young, nonsmoking, otherwise healthy men who have recently acquired erectile dysfunction due to a focal arterial occlusion [
         <a href="#rid54">
          54,55,58-64
         </a>
         ]. Only 6 to 7 percent of men with vascular erectile dysfunction are candidates for penile revascularization with these restricted criteria [
         <a href="#rid48">
          48
         </a>
         ]. Long-term success rates range from 50 to 67 percent [
         <a href="#rid54">
          54,55,61,64
         </a>
         ].
        </p>
        <p>
         Techniques to improve the veno-occlusive mechanism with ligation of the dorsal, cavernous, and crural veins were popular toward the end of the 20
         <sup>
          th
         </sup>
         century due to encouraging early results; however, efficacy beyond six months was minimal, and these procedures have been largely abandoned in favor of medical therapies with phosphodiesterase-5 (PDE-5) inhibitors [
         <a href="#rid57">
          57,59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H407898374">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115614.html" rel="external">
          "Society guideline links: Male sexual dysfunction"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Several surgical procedures may help men with erectile dysfunction who do not respond to pharmacologic therapy and for select patients with Peyronie's disease. The cause of the erectile dysfunction and the general health of the individual should determine the type of procedure. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Penile prosthesis
         </strong>
         – Penile prosthesis implantation has the highest satisfaction rates of all treatment options, including pharmacologic therapy, for erectile dysfunction. Prostheses have allowed men to have effective, reliable, and cosmetically acceptable erections as well as an acceptable appearance when flaccid. (See
         <a class="local">
          'Penile prostheses'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In most cases, the choice regarding the type of prosthesis is made on the basis of cosmesis and function. As a rule, men prefer the capability of inflatable prostheses to mimic the normal penis, both for its usual state of flaccidity and for its ability to become rigid for sexual activity. (See
         <a class="local">
          'Inflatable'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In contrast, older men, especially those with limited mental or manual dexterity, may prefer a semirigid rod or two-piece device, since it may be challenging to manipulate the pump and deflation mechanisms of the three-piece inflatable devices. (See
         <a class="local">
          'Semirigid'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Penile implant infection is the most serious complication of penile implants and most often requires complete removal of the device and intravenous antibiotic therapy. Penile implant salvage can be considered in select cases. (See
         <a class="local">
          'Infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Penile arterial revascularization
         </strong>
         – For most men with vascular erectile dysfunction, we suggest avoiding penile arterial revascularization given the low success rates and long-term complications (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). Penile arterial revascularization (performed at a specialty center) may be reasonable for young, nonsmoking, otherwise healthy men without evidence of generalized vascular disease, diabetes, or hypertension who have recently acquired erectile dysfunction secondary to a focal arterial occlusion. (See
         <a class="local">
          'Penile revascularization'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Penile venous surgery not recommended
         </strong>
         – For men with erectile dysfunction with veno-occlusive disease, we suggest not performing penile venous surgery given the low success rates and the availability of effective oral medications such as phosphodiesterase-5 (PDE-5) inhibitors (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). (See
         <a class="local">
          'Penile revascularization'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Batty GD, Li Q, Czernichow S, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol 2010; 56:1908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson G, Montorsi P, Adams MA, et al. Cardiovascular aspects of sexual medicine. J Sex Med 2010; 7:1608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz BG, Kloner RA. Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation 2011; 123:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shin D, Pregenzer G Jr, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev 2011; 19:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarow JP. Risk factors for penile prosthetic infection. J Urol 1996; 156:402.
          </a>
         </li>
         <li class="breakAll">
          Lewis, RW, McLaren, R. Reoperation for penile prosthesis implantation. Probl Urol 1993; 7:381.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Carson CC, Cleves MA, Delk JR 2nd. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol 1998; 159:1537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bishop JR, Moul JW, Sihelnik SA, et al. Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections. J Urol 1992; 147:386.
          </a>
         </li>
         <li class="breakAll">
          Wolf JS, Bennett CJ, Dmochowski RR, et al. The best practice policy statement of urologic surgery antimicrobial prophylaxis. American Urological Association, 2008. Available at: auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/antimicroprop08.pdf (Accessed on February 11, 2010).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gross MS, Phillips EA, Balen A, et al. The Malleable Implant Salvage Technique: Infection Outcomes after Mulcahy Salvage Procedure and Replacement of Infected Inflatable Penile Prosthesis with Malleable Prosthesis. J Urol 2016; 195:694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lue TF. Erectile dysfunction. N Engl J Med 2000; 342:1802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol 2018; 200:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montague DK, Angermeier KW. Penile prosthesis implantation. Urol Clin North Am 2001; 28:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khoudary KP, Morgentaler A. Design considerations in penile prostheses: the American Medical Systems product line. J Long Term Eff Med Implants 1997; 7:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scott FB, Bradley WE, Timm GW. Management of erectile impotence. Use of implantable inflatable prosthesis. Urology 1973; 2:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Cleves MA, Delk JR 2nd. Ultrex cylinders: problems with uncontrolled lengthening (the S-shaped deformity). J Urol 1996; 155:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry GD, Wilson SK. Updates in inflatable penile prostheses. Urol Clin North Am 2007; 34:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lightfoot AJ, Rosevear HM, Kreder KJ. Inflatable penile prostheses: an update. Curr Opin Urol 2010; 20:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK. Penile prostheses at the millennium. Contemporary Urology 2001; 13:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quesada ET, Light JK. The AMS 700 inflatable penile prosthesis: long-term experience with the controlled expansion cylinders. J Urol 1993; 149:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study. J Urol 2001; 166:932.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manfredi C, Fortier É, Faix A, Martínez-Salamanca JI. Penile Implant Surgery Satisfaction Assessment. J Sex Med 2021; 18:868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carson CC, Mulcahy JJ, Govier FE. Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. AMS 700CX Study Group. J Urol 2000; 164:376.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Henry GD, Delk JR Jr, Cleves MA. The mentor Alpha 1 penile prosthesis with reservoir lock-out valve: effective prevention of auto-inflation with improved capability for ectopic reservoir placement. J Urol 2002; 168:1475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knoll LD, Henry G, Culkin D, et al. Physician and patient satisfaction with the new AMS 700 momentary squeeze inflatable penile prosthesis. J Sex Med 2009; 6:1773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salem EA, Wilson SK, Neeb A, et al. Mechanical reliability of AMS 700 CX improved by parylene coating. J Sex Med 2009; 6:2615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry GD, Kansal NS, Callaway M, et al. Centers of excellence concept and penile prostheses: an outcome analysis. J Urol 2009; 181:1264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKim SE, Carson CC 3rd. AMS 700 inflatable penile prosthesis with InhibiZone. Expert Rev Med Devices 2010; 7:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Delk JR, Salem EA, Cleves MA. Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades. J Sex Med 2007; 4:1074.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bettocchi C, Palumbo F, Spilotros M, et al. Patient and partner satisfaction after AMS inflatable penile prosthesis implant. J Sex Med 2010; 7:304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollenbeck BK, Miller DC, Ohl DA. The utility of lockout valve reservoirs in preventing autoinflation in penile prostheses. Int Urol Nephrol 2002; 34:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carson CC 3rd. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004; 171:1611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hellstrom WJ, Hyun JS, Human L, et al. Antimicrobial activity of antibiotic-soaked, Resist-coated Bioflex. Int J Impot Res 2003; 15:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolter CE, Hellstrom WJ. The hydrophilic-coated inflatable penile prosthesis: 1-year experience. J Sex Med 2004; 1:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Zumbe J, Henry GD, et al. Infection reduction using antibiotic-coated inflatable penile prosthesis. Urology 2007; 70:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cakan M, Demirel F, Karabacak O, et al. Risk factors for penile prosthetic infection. Int Urol Nephrol 2003; 35:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gross AJ, Sauerwein DH, Kutzenberger J, Ringert RH. Penile prostheses in paraplegic men. Br J Urol 1996; 78:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dos Reis JM, Glina S, Da Silva MF, Furlan V. Penile prosthesis surgery with the patient under local regional anesthesia. J Urol 1993; 150:1179.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaufman JJ. Penile prosthetic surgery under local anesthesia. J Urol 1982; 128:1190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Cleves MA, Delk JR 2nd. Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 2001; 165:825.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furlow WL, Goldwasser B, Gundian JC. Implantation of model AMS 700 penile prosthesis: long-term results. J Urol 1988; 139:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson SK, Delk JR 2nd. Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 1995; 153:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fishman IJ, Scott FB, et al. Rescue procedure: an alternative to complete removal for treatment of infected penile prosthesis. J Urol 1987; 137:202A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry GD, Wilson SK, Delk JR 2nd, et al. Penile prosthesis cultures during revision surgery: a multicenter study. J Urol 2004; 172:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hauri D. Penile revascularization surgery in erectile dysfunction. Urol Int 2003; 70:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peppas DS, Moul JW, McLeod DG. Candida albicans corpora abscess following penile prosthesis placement. J Urol 1988; 140:1541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carson CC. Diagnosis, treatment and prevention of penile prosthesis infection. Int J Impot Res 2003; 15 Suppl 5:S139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DePalma RG, Olding M, Yu GW, et al. Vascular interventions for impotence: lessons learned. J Vasc Surg 1995; 21:576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsons CL, Stein PC, Dobke MK, et al. Diagnosis and therapy of subclinically infected prostheses. Surg Gynecol Obstet 1993; 177:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverstein AD, Henry GD, Evans B, et al. Biofilm formation on clinically noninfected penile prostheses. J Urol 2006; 176:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brant MD, Ludlow JK, Mulcahy JJ. The prosthesis salvage operation: immediate replacement of the infected penile prosthesis. J Urol 1996; 155:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henry GD, Wilson SK, Delk JR 2nd, et al. Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study. J Urol 2005; 173:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulcahy JJ. Surgical management of penile prosthesis complications. Int J Impot Res 2000; 12 Suppl 4:S108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trost LW, Munarriz R, Wang R, et al. External Mechanical Devices and Vascular Surgery for Erectile Dysfunction. J Sex Med 2016; 13:1579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vardi Y, Gruenwald I, Gedalia U, et al. Evaluation of penile revascularization for erectile dysfunction: a 10-year follow-up. Int J Impot Res 2004; 16:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol 2005; 174:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rao DS, Donatucci CF. Vasculogenic impotence. Arterial and venous surgery. Urol Clin North Am 2001; 28:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babaei AR, Safarinejad MR, Kolahi AA. Penile revascularization for erectile dysfunction: a systematic review and meta-analysis of effectiveness and complications. Urol J 2009; 6:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein I. Overview of types and results of vascular surgical procedures for impotence. Cardiovasc Intervent Radiol 1988; 11:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machtens S, Gänsslen A, Pohlemann T, Stief CG. Erectile dysfunction in relation to traumatic pelvic injuries or pelvic fractures. BJU Int 2001; 87:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawanishi Y, Kimura K, Nakanishi R, et al. Penile revascularization surgery for arteriogenic erectile dysfunction: the long-term efficacy rate calculated by survival analysis. BJU Int 2004; 94:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarramon JP, Malavaud B, Bertrand N, Rischmann P. [Vascular microsurgery in the treatment of vasculogenic erectile dysfunction: clinical experience apropos of 115 operations performed according to 2 different surgical techniques]. Prog Urol 1999; 9:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trombetta C, Liguori G, Siracusano S, et al. Laparoscopically assisted penile revascularization for vasculogenic impotence: 2 additional cases. J Urol 1997; 158:1783.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munarriz R, Uberoi J, Fantini G, et al. Microvascular arterial bypass surgery: long-term outcomes using validated instruments. J Urol 2009; 182:643.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8092 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21109113" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20388161" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Cardiovascular aspects of sexual medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21200016" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21135596" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Erectile dysfunction: a disease marker for cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8683689" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Risk factors for penile prosthetic infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8683689" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Risk factors for penile prosthetic infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9554349" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1732600" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1732600" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Use of glycosylated hemoglobin to identify diabetics at high risk for penile periprosthetic infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26343986" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The Malleable Implant Salvage Technique: Infection Outcomes after Mulcahy Salvage Procedure and Replacement of Infected Inflatable Penile Prosthesis with Malleable Prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10853004" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Erectile dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29746858" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Erectile Dysfunction: AUA Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11402587" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Penile prosthesis implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10168541" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Design considerations in penile prostheses: the American Medical Systems product line.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4766860" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Management of erectile impotence. Use of implantable inflatable prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7490811" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Ultrex cylinders: problems with uncontrolled lengthening (the S-shaped deformity).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17983893" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Updates in inflatable penile prostheses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20625296" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Inflatable penile prostheses: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Penile prostheses at the millennium
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8417215" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The AMS 700 inflatable penile prosthesis: long-term experience with the controlled expansion cylinders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11490249" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis: results of a 2 center study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33903044" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Penile Implant Surgery Satisfaction Assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10893589" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. AMS 700CX Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12352421" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The mentor Alpha 1 penile prosthesis with reservoir lock-out valve: effective prevention of auto-inflation with improved capability for ectopic reservoir placement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19473458" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Physician and patient satisfaction with the new AMS 700 momentary squeeze inflatable penile prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19619145" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Mechanical reliability of AMS 700 CX improved by parylene coating.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19152945" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Centers of excellence concept and penile prostheses: an outcome analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20420554" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : AMS 700 inflatable penile prosthesis with InhibiZone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17627751" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Long-term survival of inflatable penile prostheses: single surgical group experience with 2,384 first-time implants spanning two decades.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19758282" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Patient and partner satisfaction after AMS inflatable penile prosthesis implant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12899233" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The utility of lockout valve reservoirs in preventing autoinflation in penile prostheses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15017233" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12605236" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Antimicrobial activity of antibiotic-soaked, Resist-coated Bioflex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16429621" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The hydrophilic-coated inflatable penile prosthesis: 1-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17826502" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Infection reduction using antibiotic-coated inflatable penile prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15072498" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Risk factors for penile prosthetic infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8813925" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Penile prostheses in paraplegic men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8371384" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Penile prosthesis surgery with the patient under local regional anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7154170" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Penile prosthetic surgery under local anesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11176479" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Long-term followup of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3352035" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Implantation of model AMS 700 penile prosthesis: long-term results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7861509" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Inflatable penile implant infection: predisposing factors and treatment suggestions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Rescue procedure: an alternative to complete removal for treatment of infected penile prosthesis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15201759" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Penile prosthesis cultures during revision surgery: a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12592042" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Penile revascularization surgery in erectile dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3193534" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Candida albicans corpora abscess following penile prosthesis placement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14551594" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Diagnosis, treatment and prevention of penile prosthesis infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7707563" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Vascular interventions for impotence: lessons learned.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8211603" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Diagnosis and therapy of subclinically infected prostheses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16890680" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Biofilm formation on clinically noninfected penile prostheses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7490819" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The prosthesis salvage operation: immediate replacement of the infected penile prosthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15592039" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Revision washout decreases penile prosthesis infection in revision surgery: a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11035396" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Surgical management of penile prosthesis complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27770853" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : External Mechanical Devices and Vascular Surgery for Erectile Dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15073607" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Evaluation of penile revascularization for erectile dysfunction: a 10-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15947645" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Chapter 1: The management of erectile dysfunction: an AUA update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11402583" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Vasculogenic impotence. Arterial and venous surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19241332" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Penile revascularization for erectile dysfunction: a systematic review and meta-analysis of effectiveness and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3147139" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Overview of types and results of vascular surgical procedures for impotence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11298032" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Erectile dysfunction in relation to traumatic pelvic injuries or pelvic fractures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15291868" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Penile revascularization surgery for arteriogenic erectile dysfunction: the long-term efficacy rate calculated by survival analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10555225" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : [Vascular microsurgery in the treatment of vasculogenic erectile dysfunction: clinical experience apropos of 115 operations performed according to 2 different surgical techniques].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9334601" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Laparoscopically assisted penile revascularization for vasculogenic impotence: 2 additional cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19539333" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Microvascular arterial bypass surgery: long-term outcomes using validated instruments.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
